维普期刊资源整合服务平台（V6.5）

178篇 您的检索式：作者名="CASTELL DO"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Esomeprazole ( 40 mg ) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis 显示文摘	Castell DO Kahrilas PJ Richter JE	2002	Am J Gastroentero12002，97，3：	1
2	Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphatia显示文摘	Hila A Castell JA Castell DO	2001	Clin Gastroenterol2001，33，：	1
3	Classification of oesophageal motility abnormalities 显示文摘	Spechler S J Castell DO	2001	Gut2001，49，：	1
4	Radial and longitudinal asymmetry of the human pharynx显示文摘	Sears VW Castell JA Casiell DO		0，，：	1
5	Pharyngeal and upper esoph- ageal sphincter manometry in the evaluation of dysphagia显示文摘	Hila A Castell JA Castell DO	2001	J Clin Gastroenterol2001，33，5：	1
6	High amplitude, peri- staltic esophageal contractions associated with chest pain and/or dysphagia显示文摘	Benjamin SB Gerhardt DC Castell DO	1979	Gastroenterology1979，77，3：	1
7	Pharyngeal and upper esophageal sphincter manometry in humans 显示文摘	Castell JA Dalton CB Castell DO	1990	Am J Physiol1990，258，21：	1
8	lntragastric acid suppres- sion and pharmacokinetics of twice-daily esomeprazole: a ran domized, three-way crossover study 显示文摘	Katz PO Castell DO Chen Y	2004	Aliment Pharmacol Ther2004，20，4：	1
9	Up- dated guidelines for the diagnosis and treatment of gastroesophageal reflux disease 显示文摘	De Vault KR Castel DO American College of Gastroenterology	2005	Am J Gastroentero12005，100，：	1
10	Classification of oesophageal motility abnormalities 显示文摘	Spechler SJ Castell DO	2001	Gut2001，49，1：	1
11	Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function:the results of a gallup survey conducted on behalf of the American Gastroenterological Association显示文摘	Shaker R Castell DO Schoenfeld PS etal	2003	Am J Gastroenterol2003，98，7：	1
12	Esophageal motility disorders and chest pai n显示文摘	Castell DO	1991	Med Clin North Amer1991，75，：	1
13	老年人的进食与吞咽障碍显示文摘	Castell DO 陈胜坚陈淑端	1989	国外医学(消化系疾病分册)1989，，03：	1
14	Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease显示文摘	DeVault KR Castell DO	2005	AmJ Gastroenterol2005，100，：	1
15	Nocturnal acid break-through: pH, drugs and bugs 显示文摘	Tutuian R Katz PO Castell DO	2004	Eur J Gastroenterol Hepatol2004，16，5：	1
16	Importance of adequate acid suppression in the management of Barrett's esophagus显示文摘	Castell DO Katzka DA	1999	Gastroenterology1999，117，6：	1
17	Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole显示文摘	Katz PO Hatlebakk JG Castell DO	2000	Aliment Pharmacol Ther2000，14，6：	1
18	Ranitidine controls nocturnalgastric acid breakthrough on omeprazole: a controlled study innormal subjects 显示文摘	Peghini PL Katz PO Castell DO	1998	Gastroenterology1998，115，6：	1
19	Addition of a H2 receptor antago-nist to PPI improves acid control and decreases nocturnal acid break-through 显示文摘	Mainie I Tutuian R Castell DO	2008	J Clin Gastroenterol2008，42，6：	1
20	The critical analysis of new PPI esomeprazole显示文摘	Castell DO Fennerty MB Johnson DA	2001	AGA New Drug Review2001，1，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示